Ecnoglutide
XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults
Hangzhou Sciwind Biosciences Co · Phase 1 · Completed · Enrollment 87
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Cohort 1A/1B | Obesity + T2D | n/r | 6 | n/r | n/r |
| Cohort 2 | Obesity + T2D | n/r | 6 | n/r | n/r |
| Cohort 3 | Obesity + T2D | n/r | 6 | n/r | n/r |
| Cohort 4 | Obesity + T2D | n/r | 6 | n/r | n/r |
| Cohort 5 | Obesity + T2D | n/r | 6 | n/r | n/r |
| Cohort 6 | Obesity + T2D | n/r | 6 | n/r | n/r |